Topical Fluorometholone Versus Diclofenac Sodium in Cases With Perennial Allergic Conjunctivitis

被引:5
作者
Li, Zhiwei [1 ]
Chen, Wei [2 ]
Zhang, Yong [1 ]
Jhanji, Vishal [3 ]
Fan, Zhaoshan [1 ]
Mu, Guoying [1 ]
机构
[1] Shandong Univ, Prov Hosp, Dept Ophthalmol, Jinan 250100, Shandong, Peoples R China
[2] TianJin Eye Hosp, Tianjin, Peoples R China
[3] Chinese Univ Hong Kong, Dept Visual Sci & Ophthalmol, Hong Kong, Hong Kong, Peoples R China
来源
EYE & CONTACT LENS-SCIENCE AND CLINICAL PRACTICE | 2015年 / 41卷 / 05期
关键词
Diclofenac sodium; Fluorometholone; Perennial allergic conjunctivitis;
D O I
10.1097/ICL.0000000000000127
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Purpose: To compare the efficacy of diclofenac sodium (DS) 0.1% and fluorometholone (FL) 0.1% in patients with perennial allergic conjunctivitis. Methods: Fluorometholone 0.1% or DS 0.1% eye drops were topically administrated 4 times daily for 4 weeks in patients with perennial allergic conjunctivitis. Assessment was conducted with a 4-point rating scale (0=none, 1=mild, 2=moderate, and 3=severe) for 4 signs and 5 symptoms. Results: Two hundred sixty-one patients were recruited. The demographics and baseline skin prick scores between both groups were comparable. Mean baseline scores in DS and FL group were 6.77 +/- 2.24 and 6.34 +/- 2.10, respectively. The scores rapidly decreased to 3.28 +/- 1.47 and 2.69 +/- 1.44 on day 7. Diclofenac sodium expressed a slower effect compared with FL within the first 3 days of treatment (P=0.01). Conclusions: The efficacy of topical FL and DS was comparable for the management of cases with perennial allergic conjunctivitis. However, FL led to a more rapid alleviation of signs and symptoms as compared with DS in early days after the initiation of treatment.
引用
收藏
页码:310 / 313
页数:4
相关论文
共 13 条
[1]   The pathophysiology of ocular allergy: A review [J].
Chigbu, De Gaulle I. .
CONTACT LENS & ANTERIOR EYE, 2009, 32 (01) :3-15
[2]   The anti-bacterial action of diclofenac shown by inhibition of DNA synthesis [J].
Dastidar, SG ;
Ganguly, K ;
Chaudhuri, K ;
Chakrabarty, AN .
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2000, 14 (03) :249-251
[3]  
Dehar N, 2012, INT J APPL BASIC MED, V2, P25, DOI DOI 10.4103/2229-516X.96799
[4]   Treatment of allergic conjunctivitis: results of a 1-month, single-masked randomized study [J].
Figus, Michele ;
Fogagnolo, Paolo ;
Lazzeri, Stefano ;
Capizzi, Federica ;
Romagnoli, Mariachiara ;
Canovetti, Annalisa ;
Iester, Michele ;
Ferreras, Antonio ;
Rossetti, Luca ;
Nardi, Marco .
EUROPEAN JOURNAL OF OPHTHALMOLOGY, 2010, 20 (05) :811-818
[5]   Comparison of Efficacy of Bromfenac Sodium 0.1% Ophthalmic Solution and Fluorometholone 0.02% Ophthalmic Suspension for the Treatment of Allergic Conjunctivitis [J].
Fujishima, Hiroshi ;
Fukagawa, Kazumi ;
Takano, Yoji ;
Tanaka, Mari ;
Okamoto, Shigeki ;
Miyazaki, Dai ;
Yamada, Jun ;
Fukushima, Atsuki ;
Uchio, Eiichi ;
Nakagawa, Yayoi .
JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS, 2009, 25 (03) :265-269
[6]   EFFECT OF DICLOFENAC SODIUM ON THE ARACHIDONIC-ACID CASCADE [J].
KU, EC ;
LEE, W ;
KOTHARI, HV ;
SCHOLER, DW .
AMERICAN JOURNAL OF MEDICINE, 1986, 80 (4B) :18-23
[7]   Ophthalmologic adverse effects of systemic corticosteroids [J].
Lebreton, O. ;
Weber, M. .
REVUE DE MEDECINE INTERNE, 2011, 32 (08) :506-512
[8]   Comparative Evaluation of Topical Pranoprofen and Fluorometholone in Cases With Chronic Allergic Conjunctivitis [J].
Li, Zhiwei ;
Mu, Guoying ;
Chen, Wei ;
Gao, Lufang ;
Jhanji, Vishal ;
Wang, Lihua .
CORNEA, 2013, 32 (05) :579-582
[9]   Locally administered ocular corticosteroids - Benefits and risks [J].
McGhee, CNJ ;
Dean, S ;
Danesh-Meyer, H .
DRUG SAFETY, 2002, 25 (01) :33-55
[10]   Recent Patents and Emerging Therapeutics in the Treatment of Allergic Conjunctivitis [J].
Mishra, Gyan P. ;
Tamboli, Viral ;
Jwala, Jwala ;
Mitra, Ashim K. .
RECENT PATENTS ON INFLAMMATION & ALLERGY DRUG DISCOVERY, 2011, 5 (01) :26-36